profit from every $100 of sales.
$0$100
Health Catalyst
$1.51+11.03% today
-35.7% in 1 year
1-year low $1.001-year high $2.99
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Health Catalyst sold, what it kept, and what it did with the cash.
Sales went from $276 million in 2022 to $311 million in 2025, with -$178 million of profit last year.
SalesProfit
Health Catalyst vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Health Catalyst | No profit yet | ||
 GE HealthCare Technologies | 18.0× · Fair price | ||
 BrightSpring Health Services | 74.3× · Very expensive | ||
 Tempus AI | No profit yet | ||
 HealthEquity | 39.8× · Expensive |
AI analysis
An AI analyst reads Health Catalyst's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 276 | 296 | 307 | 311 | |
| 133 | 132 | 141 | 152 | |
| -140 | -100 | -58 | -43 | |
| -92 | -58 | -11 | -103 | |
| -137 | -118 | -70 | -178 | |
| -2.63 | -2.09 | -1.15 | -2.55 | |
| 48.2% | 44.5% | 45.9% | 48.7% | |
| -50.7% | -33.8% | -18.8% | -13.7% | |
| -49.7% | -39.9% | -22.7% | -57.2% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 752 | 702 | 859 | 503 |
| Cash | 116 | 106 | 250 | 51 |
| Total debt | 248 | 249 | 402 | 171 |
| Total liabilities | 327 | 335 | 494 | 257 |
| 425 | 367 | 365 | 246 | |
| 54 | 56 | 60 | 70 | |
| -16.4% | -12.8% | -5.4% | -29.0% | |
| -32.3% | -32.2% | -19.0% | -72.4% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -35 | -33 | 15 | 1 | |
| 17 | 14 | 16 | 22 | |
| -53 | -47 | -2 | -21 | |
| Dividends paid | – | – | – | – |
| 8 | 2 | 0 | 5 | |
| 72 | 56 | 40 | 27 |
Valuation
- –
- 13.4×
- –
- 0.7×
- 0.4×
- –
- –
- -18.1%
- -154.8%
- 0.0%
Profitability
- 48.7%
- -13.7%
- -57.2%
- -30.8%
- -18.7%
- -22.5%
- -99.8%
- -64.4%
- -19.1%
- 14.6%
Growth
- +4.0%
- –
- +87.1%
- –
- +10.1%
Financial health
- –
- 0.14
- 4.6%
- -2.7×
- 1.69
- 1.69
- 0.73
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 23%of 946
Bottom 14%of 872
Bottom 24%of 868
Bottom 5%of 986
What analysts expect
- Average price target
- $2.50
- Range
- $2.00 – $3.00
- 2 analysts
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 11, 2026 | 0.02 | 0.01 | +100.0% |
| Mar 12, 2026 | 0.08 | 0.09 | −11.1% |
| Nov 10, 2025 | 0.06 | 0.05 | +20.0% |
| Aug 7, 2025 | 0.04 | 0.03 | +33.3% |
| May 7, 2025 | 0.01 | 0.01 | +0.0% |
| Feb 26, 2025 | 0.04 | 0.11 | −63.6% |
| Nov 6, 2024 | 0.07 | 0.10 | −30.0% |
| Aug 7, 2024 | 0.12 | 0.09 | +33.3% |
News
GLP-1s can save health system money if priced below $350 a month: analysisSeeking Alpha · Nov 14, 2026How to figure out a key question this open-enrollment season: Are you overpaying for health insurance?MarketWatch · Nov 13, 2026Obamacare Subsidies Lapsed. Here's Why Health Insurer Stocks Are Watching the New Congress.Yahoo Finance · Nov 8, 2026Notable healthcare headlines for the week: Moderna, Pfizer, and CVS Health in focusSeeking Alpha · Nov 8, 2026The Healthcare ETF Showdown: Broad Global Health or Targeted Pharma Power?Yahoo Finance · Nov 7, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
17No pass
Benjamin Graham
64Pass
Philip Fisher
20No pass
Peter Lynch
34No pass
Joel Greenblatt
0No pass
Charlie Munger
24No pass
Terry Smith
19No pass
Questions about Health Catalyst
Is Health Catalyst a good stock to buy?
A business with weak numbers that is not profitable yet. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Health Catalyst AI analysis
What does Health Catalyst do?
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. It is in Medical - Healthcare Information Services.
Does Health Catalyst pay a dividend?
No. Health Catalyst does not pay a dividend at the moment; in 2025 it returned $5.00 million to shareholders by buying back its own shares.
Is Health Catalyst stock halal?
No. Health Catalyst does not pass our halal screen: its debt is 149% of its market value, at or above the 33% limit. How we check
How has Health Catalyst stock done over the past year?
Down 35.7% over the past twelve months, to $1.51. It traded between $1.00 and $2.99 and is 49.5% below its high.
Who are Health Catalyst's competitors?
The largest listed companies in the same industry are GE HealthCare Technologies, BrightSpring Health Services, Tempus AI and HealthEquity. The peers table on this page compares their profit, growth and price with Health Catalyst's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.